scholarly journals Do patients with oxyphilic cell papillary thyroid carcinoma have a poor prognosis? Analysis of the surveillance, epidemiology, and end results database 2004-2013 with propensity score matching

Oncotarget ◽  
2017 ◽  
Vol 8 (44) ◽  
pp. 77075-77085 ◽  
Author(s):  
Chunping Liu ◽  
Qiuyang Zhao ◽  
Wen Zeng ◽  
Chen Chen ◽  
Jie Ming ◽  
...  
Keyword(s):  
Papillary Thyroid Carcinoma ◽  
Propensity Score ◽  
Thyroid Carcinoma ◽  
Propensity Score Matching ◽  
Poor Prognosis ◽  
Papillary Thyroid ◽  
Oxyphilic Cell ◽  
End Results

Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma

2021 ◽  
pp. 104658
Author(s):  
Sen Hou ◽  
Yu-Ying Zhuang ◽  
Qiu-Yu Lin ◽  
Zhen Chen ◽  
Hong-Guang Zhao ◽  
...  
Keyword(s):  
Papillary Thyroid Carcinoma ◽  
Thyroid Carcinoma ◽  
Poor Prognosis ◽  
Papillary Thyroid

scholarly journals Should a family history of papillary thyroid carcinoma indicate more aggressive therapy in patients with this tumor?

2014 ◽  
Vol 58 (8) ◽  
pp. 812-816 ◽  
Author(s):  
Pedro Weslley Rosario ◽  
Maria Regina Calsolari
Keyword(s):  
Lymph Node ◽  
Family History ◽  
Papillary Thyroid Carcinoma ◽  
Thyroid Carcinoma ◽  
Lymph Node Dissection ◽  
Poor Prognosis ◽  
Tumor Resection ◽  
Papillary Thyroid ◽  
Node Dissection ◽  
History Of

Objective To determine whether the currently recommended therapy for papillary thyroid carcinoma (PTC) that show no classical factors indicating a poor prognosis is also effective in cases with a family history of this tumor. Subjects and methods: Forty-two patients were studied; 10 were submitted to lobectomy and 32 to total thyroidectomy, including 23 without lymph node dissection and 9 with lymph node dissection. None of the patients received radioiodine or was maintained under TSH suppression. Results No case of recurrence was detected by imaging methods and there was no increase in thyroglobulin or antithyroglobulin antibodies during follow-up (24 to 72 months). Conclusion The treatment usually recommended for patients with PTC does not need to be modified in the presence of a family history of this tumor if no factors indicating a poor prognosis are present (tumor ≤2 cm, non-aggressive histology, no extensive extrathyroid invasion or important lymph node involvement, complete tumor resection, no evidence of persistent disease after surgery).

Abstract 3117: Pleiotrophin is a marker of poor prognosis in Middle Eastern papillary thyroid carcinoma

2016 ◽  
Author(s):  
Shaham Beg ◽  
Maqbool Ahmed ◽  
Azhar Hussein ◽  
Rong Bu ◽  
Zeeshan Qadri ◽  
...  
Keyword(s):  
Papillary Thyroid Carcinoma ◽  
Thyroid Carcinoma ◽  
Poor Prognosis ◽  
Middle Eastern ◽  
Papillary Thyroid

CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma

2017 ◽  
Vol 18 (3) ◽  
pp. 273-284 ◽  
Author(s):  
Dingyuan Luo ◽  
Haibo Chen ◽  
Penghui Lu ◽  
Xiaojuan Li ◽  
Miaoyun Long ◽  
...  
Keyword(s):  
Papillary Thyroid Carcinoma ◽  
Thyroid Carcinoma ◽  
Poor Prognosis ◽  
Papillary Thyroid

scholarly journals Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma

2018 ◽  
Vol 16 (1) ◽  
Author(s):  
Lei Shen ◽  
Chunhua Qian ◽  
Huimin Cao ◽  
Zhongrui Wang ◽  
Tingxian Luo ◽  
...  
Keyword(s):  
Papillary Thyroid Carcinoma ◽  
Thyroid Carcinoma ◽  
Poor Prognosis ◽  
Solute Carrier Family ◽  
Papillary Thyroid ◽  
Solute Carrier

scholarly journals AP-2α expression in papillary thyroid carcinoma predicts tumor progression and poor prognosis

2018 ◽  
Vol Volume 10 ◽  
pp. 2615-2625 ◽  
Author(s):  
Hong Rong Wu ◽  
Jian Zhang
Keyword(s):  
Papillary Thyroid Carcinoma ◽  
Thyroid Carcinoma ◽  
Tumor Progression ◽  
Poor Prognosis ◽  
Papillary Thyroid
Sign in / Sign up

Export Citation Format

Share Document